Compare BHVN & WLTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BHVN | WLTH |
|---|---|---|
| Founded | 2013 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance: Consumer Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 1.2B |
| IPO Year | 2022 | N/A |
| Metric | BHVN | WLTH |
|---|---|---|
| Price | $10.83 | $11.14 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 14 | 8 |
| Target Price | ★ $29.08 | $12.86 |
| AVG Volume (30 Days) | ★ 2.0M | 1.5M |
| Earning Date | 05-11-2026 | 05-18-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 26.08 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $10.61 |
| Revenue Next Year | N/A | $23.50 |
| P/E Ratio | ★ N/A | $10.57 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $7.48 | $7.20 |
| 52 Week High | $24.06 | $14.12 |
| Indicator | BHVN | WLTH |
|---|---|---|
| Relative Strength Index (RSI) | 60.51 | 73.39 |
| Support Level | $10.75 | $7.25 |
| Resistance Level | $11.92 | $14.12 |
| Average True Range (ATR) | 0.69 | 0.44 |
| MACD | 0.26 | 0.16 |
| Stochastic Oscillator | 92.68 | 90.95 |
Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. The company's products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder and others. Its pipeline products include: BHV-2000, BHV-7000, BHV-2100, BHV-8000, BHV-1310, BHV-1300, BHV-1400, BHV-1600, BHV-1530, and BHV-1500.
Wealthfront Corp is a technology company that built a financial solutions platform for digital natives. Its platform is designed to address the needs of the wealth builders within these generations.